Jared Gollob
Chief Tech/Sci/R&D Officer en KYMERA THERAPEUTICS, INC. .
Fortuna: 4 M $ al 31/03/2024
Perfil
Jared Gollob is currently the Chief Medical Officer at Kymera Therapeutics, Inc. Prior to this, he was the Global VP-Medical Affairs & Clinical Development at Alnylam Pharmaceuticals, Inc. from 2012 to 2018.
Before that, he was the Director-Biologic Therapy Program at Duke University from 2002 to 2007.
Dr. Gollob received his undergraduate and doctorate degrees from The Trustees of Columbia University in The City of New York.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 04/03/2024 | 95 740 ( 0.16% ) | 4 M $ | 31/03/2024 |
Cargos activos de Jared Gollob
| Empresas | Cargo | Inicio |
|---|---|---|
| KYMERA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/09/2018 |
Antiguos cargos conocidos de Jared Gollob.
| Empresas | Cargo | Fin |
|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/08/2018 |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | Corporate Officer/Principal | 01/09/2007 |
Formación de Jared Gollob.
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
| KYMERA THERAPEUTICS, INC. | Health Technology |
- Bolsa de valores
- Insiders
- Jared Gollob
